Understanding and Helping Brain Cells in Alzheimer's and Related Dementias
Strategies for targeting astrocyte reactivity in Alzheimer's disease and related dementias
This project explores how certain brain cells, called astrocytes, contribute to Alzheimer's disease and similar memory conditions, hoping to find new ways to help patients.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kentucky NIH-funded |
| Lab location | 1 site (Lexington, United States) |
| Project ID | NIH-11126072 on NIH RePORTER |
What this research studies
Our team is looking closely at how astrocytes, a type of support cell in the brain, become overactive in conditions like Alzheimer's disease. We are using advanced techniques to see how these reactive astrocytes affect brain function in models of these diseases. The goal is to find specific ways to calm these cells down, which could improve problems like blood flow in the brain, energy use, and how brain networks communicate. We are also checking our findings in human brain samples and living individuals to make sure our discoveries are relevant to people.
Who could benefit from this research
Good fit: This foundational research is for patients with Alzheimer's disease and related dementias, as well as their families, who are interested in understanding the underlying causes of these conditions.
Not a fit: Patients seeking immediate new treatments or direct clinical trial participation may not find direct benefit from this early-stage research.
Why it matters
Potential benefit: If successful, this work could lead to new treatments that target specific brain cells to slow down or prevent the progression of Alzheimer's disease and related dementias.
How similar studies have performed: While the role of astrocytes in dementia is increasingly recognized, this large-scale programmatic approach to specifically target their reactivity is a novel and less explored area.
Where this research is happening
Lexington, United States
- University of Kentucky — Lexington, United States (Active)
Researchers
- Principal investigator: Norris, Christopher Mark — University of Kentucky
- Study coordinator: Norris, Christopher Mark
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.